Search results
Geron surges after winning first US FDA approval for blood disorder drug
Reuters via Yahoo News· 7 days agoFood and Drug Administration for its blood disorder drug. The health regulator's nod allows the...
Why Is Geron (GERN) Stock Up 18% Today?
InvestorPlace· 7 days agoGeron (NASDAQ:GERN) stock is heading higher on Friday after getting approval from the U.S. Food and Drug Administration (FDA) for RYTELO. RYTELO is the...
Geron stock steady as analysts maintain 'buy' rating with $10 target By Investing.com
Investing.com· 7 days agoThe endorsement comes after Geron's drug Rytelo (imetelstat) received approval for the treatment of...
Is Geron Stock a Buy Following Its First New Drug Approval?
Motley Fool via Yahoo Finance· 6 days agoRytelo is a new treatment for an underserved population. That's generally a recipe for success in...
'I spent 40 days and 40 nights in isolation, then went on to claim medals' - cycling is a daily...
Cycling Weekly· 3 days agoWhen I catch up with Nicholas Topley in early 2024, he has just returned from a ride. Battling...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 7 days agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Geron Corp stock opened 25% up on Friday: here's why | Invezz
Invezz· 7 days agoAre you looking for signals & alerts from pro-traders? The Food & Drug Administration approved its lead asset as a late-line treatment for myelodysplastic ...
'Doctors dismissed me for years, then diagnosed me with coeliac disease'
Women s Health· 7 days agoThere are so many varying perceptions, misconceptions and ideas surrounding coeliac disease and...
Global Relief Society Women Lead Worldwide Initiative to Support Communities in Alleviating Child...
The Yuma Sun· 1 day agoThe Church of Jesus Christ of Latter-day Saints joins with eight leading nonprofit organizations to improve maternal and child health worldwide. SALT LAKE CITY, June 12, 2024 /PRNewswire/ -- ...
Geron Shares Surge After U.S. FDA Approves Blood Disorder Drug
US News & World Report· 7 days agoCalifornia-based Geron said it will discuss the new drug's pricing and availability in a conference call with investors later in the day. Rytelo is approved for the treatment